$PMCB PharmaCyte Biotech Management Interviewed to Discuss Key Aspects of New Pancreatic Cancer Clinical Trial Design http://www.pharmacytebiotech.com/
URBF back in today at .0033. Went up from .001 to .008 before profit taking set in. Been consolidating for a few. Hopeing this is the bottom and we see the next leg up. Still like this one.